NIH Releases Final Policy on the Use of a Single Institutional Review Board for Multi-Site Research. The NIH released a final policy stating that all domestic sites of multi-site NIH-funded studies must use a single Institutional Review Board (sIRB) of record for non-exempt human subject research. The purpose of this policy is to streamline the IRB review process and reduce inefficiencies and redundancies while enhancing protections for research participants. This policy will take effect on May 25, 2017.

Clinical Trials Resource Group

Providing expertise, guidance, and hands-on support for UC Davis clinical trial Investigators & Staff

 

  • Education & Training
  • Clinical trials start up and management
  • Clinical Research Coordinator Pool
  • Monitoring & Quality Assurance
  • Coverage Analysis, Budgets, IRB
  • FDA submissions
  • Process Improvement

 

 

Download our Brochure here (PDF)

See description of services and applicable rates